What was the size, value, and vesting status of the stock award granted to BioNexus Gene Lab Corp director Low Jook Yuen?

Low Jook Yuen, a director of BioNexus Gene Lab Corp (BGLC), received a fully vested stock award of 16,129 shares of BGLC common stock on August 13, 2026, with no cash consideration required; the award was valued at $1.55 per share based on the Nasdaq closing price on August 12, 2026, and was granted under the company's 2025 Equity Incentive Plan.

How many shares of BioNexus Gene Lab Corp common stock does Low Jook Yuen hold directly after receiving the award?

Following the August 13, 2026 stock award, Low Jook Yuen directly holds 17,390 shares of BioNexus Gene Lab Corp (BGLC) common stock.

BioNexus Gene Lab Corp Director Granted Stock Award

Aug 14, 2026

BioNexus Gene Lab Corp director Low Jook Yuen received 16,129 fully vested shares valued at $1.55 per share under the 2025 Equity Incentive Plan, increasing his direct holdings to 17,390 shares.

Stock Titan

BioNexus Gene Lab Corp Director Receives 32,258-Share Equity Award

Stock Titan

BioNexus Gene Lab Corp Director Receives 32,258-Share Fully Vested Award

Stock Titan

2026-05-12

BioNexus Gene Lab Corp (BGLC)

2026-06-18

BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates

2026-06-18

BioNexus Gene Lab Corp (BGLC) Institutional Confidence